Detailed Information on Publication Record
2017
Cholinergic Anti-inflammatory Pathway and Stroke
ĎURIŠ, Kamil, Jolana LIPKOVÁ and Michal JURAJDABasic information
Original name
Cholinergic Anti-inflammatory Pathway and Stroke
Authors
ĎURIŠ, Kamil (203 Czech Republic, guarantor, belonging to the institution), Jolana LIPKOVÁ (203 Czech Republic, belonging to the institution) and Michal JURAJDA (203 Czech Republic, belonging to the institution)
Edition
Current Drug Delivery, Sharjah, Bentham Science Publishers, 2017, 1567-2018
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
United Arab Emirates
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.078
RIV identification code
RIV/00216224:14110/17:00095205
Organization unit
Faculty of Medicine
UT WoS
000405313200002
Keywords in English
Cerebral ischemia; cholinergic anti-inflammatory pathway; inflammation; intracerebral hemorrhage; stroke; subarachnoid hemorrhage; Vagus nerve stimulation; alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR)
Tags
Tags
International impact, Reviewed
Změněno: 20/3/2018 14:19, Soňa Böhmová
Abstract
V originále
Background: Stroke is devastating cerebrovascular event which is responsible for 6.7 million deaths each year worldwide. Inflammation plays an important role in the pathophysiology of stroke. Targeting inflammation after stroke is highly actual topic for both experimental and clinical research. Methods: Research articles related to cholinergic anti-inflammatory pathway (CHAIP) and stroke were reviewed. The first part of review describes the basic characteristics of inflammatory response after stroke, main components and function of CHAIP. The second part reviews studies focused on CHAIP as a therapeutic target for ischemic and hemorrhagic stroke. Both pharmacological stimulation of alpha 7 nAChR and vagus nerve stimulation after stroke are reviewed. Results: Cholinergic anti-inflammatory pathway (CHAIP) is a physiological mechanism by which central nervous system regulates immune response and controls inflammation. Vagus nerve, spleen and alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR) are the main components of CHAIP. Conclusion: Targeting cholinergic anti-inflammatory pathway is a promising way of immunomodulation which attenuates inflammation in a complex manner without causing immunosuppression.
Links
GP14-23773P, research and development project |
|